Type 1 diabetes (T1D) affects over 2 million people in the United States and has no known cure. The discovery and first use of insulin in humans 102 years ago marked a revolutionary course of treatment for the disease, and although the formulations and delivery systems have advanced, insulin...
Nearly 50years after the autoimmune nature of type 1 diabetes was discovered, no therapy has been approved to alter the course of the disease at any stage. However, during that same period, technology has been delivering tools to help patients achieve better glycemic control and reduce the ...
at the Harvard Stem Cell Institute in Cambridge, Massachusetts, reported the first successful generation of insulin-producing cells from the skin cells of people with type 1 diabetes.Roger Highfieldspoke to Melton about the personal driving force behind his research, and where he sees work on stem...
Although the exact cause of type 1 diabetes isn’t known, it’s thought to be caused by an autoimmune response where the body attacks and destroys the pancreas’ beta cells, the cells that produceinsulin. For years, researchers have looked at‘curing’ diabetesby using stem cells to createin...
such as type 1 diabetes (T1D), a chronic metabolic disease that results from the autoimmune destruction of the insulin-producing β-cells in the pancreas. The unique effective therapy for T1D nowadays is lifelong exogenous insulin administration, which involves daily insulin injections or the use ...
CureDM, Inc. is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. Theresearch teamat CureDM has discovered and is developing a novel human peptide associated with regeneration of insulin-produc...
“This is an important venture for the field of stem cell research, with real potential to transform treatment for diabetics,” said Daniel G. Anderson, an MIT professor working with Melton’s laboratory on preparations for clinical implementation. Type I diabetes, colloquially referred to as juven...
Looking ahead, the FDAhas approveda similar cell therapy developed by a Chicago-based startup for type 1 diabetes, showing a growing interest in this approach. However, Chinese researchers emphasize the need for further studies to confirm the long-term efficacy and broader applicability of their ...
Cure Thrift Shop is a high-end vintage store in the East Village, providing the thrifiting community with a curated, vibrant shopping experience for nearly 12 years. We are proudly a non-profit organization with all proceeds benefiting Type 1 diabetes re
Stem Cells for a Cure™ is a pledge by Store-A-Tooth, a service of Provia Laboratories, LLC. Our company is committed to helping raise funds for type 1 diabetes research. Learn more... about why Provia Labs is dedicated to making a difference for families with diabetes. Sitemap...